Definitive Contract 75N93023C00020
Award Date
8/1/23
Potential Completion Date
12/31/24
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Giner Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburndale, MA 02466, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Mental Health (NIMH) to Giner Inc., a small business research and development firm based in Boston. The contract, valued at $306,499.12, is for the development of point-of-care HIV viral load and drug adherence assays. This aligns with NIMH's mission to advance research on mental health and HIV/AIDS. The contract was set aside for small businesses and is part of the broader DHHS SBIR/STTR...
This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
This Small Business Innovation Research Phase I contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc. for $299,949. The contract calls for the development of a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as histoplasmosis and coccidioidomycosis. The contract responds...
This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
This is a $299,988 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Zymeron Corporation, a minority-owned small business. The contract is for the development of novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring. This contract was awarded under the Small Business Innovation...
This is a $299,976.31 Firm Fixed Price definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Guild Associates Inc. (doing business as Guild Biosciences), a small business manufacturer. The contract is for the development of point-of-care HIV viral load and drug adherence assays under the NIH's Small Business Innovation Research (SBIR) program. This work was solicited under SBIR Topic 001 of the anticipated PHS-2024-1...
This $299,040 firm-fixed-price Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective is to design and synthesize a new PLGA-based nanoparticle with an optimal protein-adjuvant formulation that combines targeting and controlled delivery for immunization...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,979.00 firm fixed-price definitive contract to Giner Inc., a small business, for the development of a rapid, point-of-care sensor for the detection of Hepatitis C virus infections. The contract has a completion date of May 31, 2023. Giner Inc. is a research and development firm based in Auburndale, Massachusetts that specializes in developing cutting-edge...
<p>This is a $187,493.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Mogene Clinical Diagnostics, LC, a small disadvantaged business. The contract is for the development of a "METHOD FOR THE DETECTION OF MINORITY POPULATIONS OF DRUG RESISTANT HIV". The award was made on August 11, 2016 with a final completion date of June 14, 2017.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...